AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Spyre Therapeutics, Inc.

$96.56 +$65.98 (+215.76%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$98.96
Day Range
$94.64$98.96
Year Range
$21.14$110.18
Market Cap
8.91B
AVG Volume
1.25M
Trailing/Forward PE
-49.52/-
PEG ratio
-1.56
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRE Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q290.49M
26 Q190.49M
25 Q490.49M
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q1688K
Net Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRE Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-178.92M
26 Q1-179.44M
25 Q4-155.2M
25 Q3-148.97M
25 Q2-206.81M
25 Q1-208.93M
24 Q4-208.02M
24 Q3-214.9M
24 Q2-185.98M
24 Q1-364.23M
Operating Income (USD) · TTM
-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRE Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-201.34M
26 Q1-201.64M
25 Q4-209.56M
25 Q3-213.64M
25 Q2-212.15M
25 Q1-214.36M
24 Q4-208.57M
24 Q3-193.23M
24 Q2-156.17M
24 Q1-271.27M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: SYRE

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 3 Nov 2026.

Spyre Therapeutics, Inc.
SYRE
Stockpicker

Video analysis: SYRE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SYRE

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.